HARRY J LEONHARDT
CIK 1286102 · GC & Chief Compliance Officer · last filed 2025-01-08
HARRY J LEONHARDT is a GC & Chief Compliance Officer who has filed 34 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for PSTX, was dated Jan 8, 2025. Across all open-market trades the lifetime net is −$356.7K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
34
-$356.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Poseida Therapeutics, Inc. (PSTX) Delisted | GC & Chief Compliance Officer | 0 | $9.50 | $0 | $0 | 5 | 2025-01-08 |
| HALOZYME THERAPEUTICS, INC. (HTI) Delisted | SVP, GC | 66,373 | — | — | $0 | 15 | 2019-04-15 |
| AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | SVP, Legal, Compliance and Cor | 39,431 | — | — | -$58.2K | 5 | 2012-03-07 |
| SENOMYX INC (SNMX) Delisted | SVP, Gen.Counsel & Corp. Sec. | 48,937 | — | — | -$298.6K | 8 | 2007-09-04 |
Recent Filings
34 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-01-08 | Poseida Therapeutics, Inc. (PSTX) Delisted | Mixed | −223,640 | $0 | EDGAR |
| 2024-03-04 | Poseida Therapeutics, Inc. (PSTX) Delisted | Mixed | +64,437 | -$67.3K | EDGAR |
| 2023-03-02 | Poseida Therapeutics, Inc. (PSTX) Delisted | Mixed | +88,449 | -$23.1K | EDGAR |
| 2022-03-01 | Poseida Therapeutics, Inc. (PSTX) Delisted | Grant (A) | +50,000 | $0 | EDGAR |
| 2021-02-05 | Poseida Therapeutics, Inc. (PSTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-04-15 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Mixed | +4,498 | -$39.3K | EDGAR |
| 2019-02-22 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Mixed | +7,453 | -$66.2K | EDGAR |
| 2019-02-15 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Mixed | +5,109 | -$44.7K | EDGAR |
| 2019-02-14 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-02-05 | HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Mixed | +9,755 | -$91.2K | EDGAR |